I am a neurobiologist with a Ph.D. in Neurobiology and Neurosciences from Ajou University, where I conducted cutting-edge research on the molecular and cellular mechanisms of neurological disorders including stroke, glioblastoma, Alzheimer's disease, and ALS. I have 2 years of experience as a research scientist at CelleBrain, a biotech startup that develops stem cell therapy for neurological disorders. There, I contributed significantly to the development of gene-modified mesenchymal stem cells for transplantation in chronic stroke and glioblastoma patients, using intricate methodologies and in-vitro assays. As a postdoctoral research fellow at the University of Maryland, I applied my expertise to develop novel therapeutic strategies utilizing metabolically glycoengineered NSCs for brain injury after cardiac arrest. I excel in stem cell modification and the meticulous assessment of its efficacy in treating challenging neurological conditions. I have multiple publications in prestigious journals and presentations at international conferences, demonstrating my strong communication and analytical skills.